Iteration index synthesis method of long-chain collagen polypeptide
Through iterative index synthesis, the long-chain collagen polypeptide precursor and the protection group is removed, which solves the problem of difficult to prepare long-chain collagen with accurate structure in the prior art, and achieves efficient and low-cost synthesis. It has the advantages of accurate chemical structure and uniform chain length.
Patent Information
- Application Number
- CN202411236683.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-09-04
Smart Images

Figure CN119019539A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of organic synthesis, and in particular relates to an iterative exponential synthesis method of long-chain collagen polypeptides. Background Art
[0002] Collagen is the most important protein in the natural extracellular matrix (ECM). It is also the most abundant and widely distributed functional protein in mammals, accounting for 25% to 30% of the total protein content. So far, a total of 29 natural collagens have been discovered. Studies have found that these collagens all have similar structural characteristics, a tight right-handed triple helix structure composed of three α-polypeptide chains, each of which contains one or more repeating sequences containing three amino acids, which are Gly-Xaa-Yaa (where Xaa and Yaa can be any amino acids, but usually proline and hydroxyproline). These repeating sequences form the central triple helix structure of collagen and are the basis for collagen stability. Collagen is widely used in the biomedical field due to its superior mechanical properties, hemostatic properties, cell growth promotion, weak antigenicity, biodegradability, collagen self-association and other important biological properties. The large-scale use of collagen has led to an increasing demand for it. The current mainstream collagen extraction and preparation methods include animal source extraction and genetic recombination. Animal-derived collagen is mainly extracted from animal tissues such as bovine tendons and pig skin. This long-chain collagen has extremely poor water solubility and is subject to risks such as immunogenicity, instability between batches, and potential pathogen transmission. As for recombinant collagen, it can be divided into three categories according to different technical paths: recombinant human collagen, recombinant humanized collagen, and recombinant long-chain collagen. However, recombinant collagen also faces problems such as poor sample stability, potential risk of endotoxin release, and complex and difficult purification processes.
[0003] Collagen-like peptide (CLP) is a short synthetic peptide obtained by chemical synthesis, which is characterized by containing (POG) nCLP has the same triple helical conformation as native collagen and is therefore widely used as a model peptide to study the stability of native collagen triple helices and guide the self-assembly of higher-order structures. Previous studies have demonstrated the potential of CLP in improving cell adhesion, proliferation, and ECM production, and have used it as a thermoresponsive bioconjugate for tissue engineering and targeted drug delivery ([1]LUO J, TONG YW. Self-Assembly of Collagen-Mimetic Peptide Amphiphiles into Biofunctional Nanofiber[J]. ACS Nano, 2011, 5(10): 7739-47. [2]MO X, ZHAO S, ZHAO J, et al. Targeting collagen damage for sustained in situ antimicrobial activities[J]. Journal of controlled release: official journal of the Controlled Release Society, 2023, 360: 122-32). Current research examines the physical and chemical properties of CLP hydrogels, such as mechanical strength, refractive index, transparency, water content, viscosity, and expansion coefficient, to establish the relationship between hydrogel performance and polypeptide molecular structure, continuously optimize the molecular design of CLP, and screen out bionic CLPs with similar composition, structure, and performance to natural ECM through high-throughput screening for use as new bionic materials.
[0004] However, it is still difficult to prepare long-chain collagen with accurate structure. Summary of the invention
[0005] The object of the present invention is to provide an iterative exponential synthesis method for preparing long-chain collagen-like polypeptides with accurate structures.
[0006] The present invention provides a method for preparing a long-chain collagen-like polypeptide, the method comprising the following steps:
[0007] (I) preparing a tripeptide protected by a protecting group;
[0008] (II) using a tripeptide protected by a protecting group as a raw material and utilizing an iterative exponential synthesis method to prepare a long-chain collagen-like polypeptide;
[0009] The structure of the tripeptide protected by the protecting group is The structure of the long-chain collagen-like polypeptide is R1 is a hydroxyl protecting group, R2 is a carboxyl protecting group, R3 is an amino protecting group, n is 2 to the power of x, and x is an integer greater than or equal to 1.
[0010] Furthermore, the method for preparing a tripeptide protected by a protecting group in step (I) comprises the following steps:
[0011] (1) Dissolving the hydroxyproline protected by a protecting group, a coupling agent and a basic catalyst in an organic solvent, adding the glycine protected by a protecting group to carry out a condensation reaction, and then adding a protecting agent, an imidazole compound and a catalyst to carry out an upper protection reaction, and obtaining a dipeptide product protected by a protecting group after purification: R4 is an amino protecting group;
[0012] (2) dissolving the dipeptide product protected by the protecting group and the deprotecting agent in an organic solvent to carry out a deprotection reaction, and obtaining the dipeptide product with the deprotected group after purification:
[0013] (3) dissolving the proline protected by the protecting group and the condensing agent in an organic solvent, adding the dipeptide product with the deprotected group, reacting under an alkaline catalyst, and obtaining the collagen-like tripeptide protected by the protecting group after purification.
[0014] Furthermore, the hydroxyl protecting group is acetyl, tert-butoxycarbonyl, tert-butyldiphenylsilyl or methoxymethyl, the carboxyl protecting group is benzyl, acetyl, tert-butoxycarbonyl, tert-butyldiphenylsilyl or methoxymethyl, and the amino protecting group is tert-butoxycarbonyl, acetyl, tert-butyldiphenylsilyl or methoxymethyl.
[0015] Further, in step (1), the hydroxyproline protected by the protecting group is Boc-L-hydroxyproline, the coupling agent is benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate; the alkaline catalyst is N,N-diisopropylethylamine, the glycine protected by the protecting group is glycine benzyl ester hydrochloride, the organic solvent is N,N-dimethylformamide, and the hydroxyproline protected by the protecting group is: benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate. The equivalent ratio of tetramethyluronium hexafluorophosphate: N, N-diisopropylethylamine: protecting group protected glycine is 1: 0.5-1: 2-5: 1-1.2, and the condensation reaction time is 1-5 hours; the protecting agent is acetic anhydride, the imidazole compound is imidazole, the catalyst is 4-dimethylaminopyridine, the equivalent ratio of acetic anhydride: imidazole: 4-dimethylaminopyridine is 1: 1-3: 1-3, and the upper protection reaction time is 1-3 hours;
[0016] In step (2), the deprotecting agent is 1,4-epoxyhexacyclic ring or its salt, the organic solvent is dichloromethane, the equivalent ratio of the dipeptide product protected by the protecting group to the deprotecting agent is 1:9-11; the mass volume ratio of the dipeptide product protected by the protecting group to the organic solvent is 1:0.5-2; the deprotection reaction time is 0.5-2 hours;
[0017] In step (3), the proline protected by the protecting group is Boc-L-proline; the condensing agent is one or a mixture of two or more of ethyl 2-oxime cyanoacetate, O-benzotriazole-tetramethyluronium hexafluorophosphate, 2-(7-azobenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate, and N,N'-diisopropylcarbodiimide; the organic solvent is dichloromethane, and the alkaline catalyst is triethylamine; the equivalent ratio of the proline protected by the protecting group, the dipeptide product of the deprotecting group, the condensing agent, and the alkaline catalyst is 1:1-3:2-4:1-2; the mass volume ratio of the proline protected by the protecting group to the organic solvent is 1:9-11; and the reaction time is 2-6 hours.
[0018] Furthermore, in step (1), the equivalent ratio of the protecting group-protected hydroxyproline: benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate: N,N-diisopropylethylamine: protecting group-protected glycine is 1:0.95:3:1.05, and the condensation reaction time is 4 hours; the equivalent ratio of the acetic anhydride: imidazole: 4-dimethylaminopyridine is 1:2:2; and the upper protection reaction time is 2 hours;
[0019] In step (2), the deprotecting agent is 1,4-epoxyhexacyclopentane hydrochloride, the equivalent ratio of the dipeptide product protected by the protecting group to the deprotecting agent is 1:10; the mass volume ratio of the dipeptide product protected by the protecting group to the organic solvent is 1:1; and the deprotection reaction time is 1 hour;
[0020] In step (3), the condensing agent is ethyl 2-oxime cyanoacetate and N,N'-diisopropylcarbodiimide, the equivalent ratio of the proline protected by the protecting group, the dipeptide product of the deprotected group, ethyl 2-oxime cyanoacetate, N,N'-diisopropylcarbodiimide, and the alkaline catalyst is 1:2:2:1.1:1.1; the mass volume ratio of the proline protected by the protecting group to the organic solvent is 1:10, and the reaction time is 4 hours.
[0021] Furthermore, the purification method of step (1) is as follows: after the reaction is completed, water is added to the reaction solution, the product is extracted with ethyl acetate, and then back-extracted with water and saturated saline, and then water is absorbed with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain;
[0022] The purification method of step (2) is: after the reaction is completed, the solvent is removed and precipitation is performed using glacial ether to obtain;
[0023] The purification method of step (3) is as follows: after the reaction is completed, water is added to the reaction solution, the product is first extracted with ethyl acetate, then back-extracted with water and saturated saline, then water is absorbed with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the product.
[0024] Further, step (II) comprises the following operations:
[0025] (a) Using a tripeptide protected by a protecting group as a raw material, a deprotection reaction is carried out with a metal catalyst in an organic solvent, and an intermediate product 1 is obtained after purification:
[0026] (b) dissolving the tripeptide protected by the protecting group and the deprotecting agent in an organic solvent to carry out a deprotection reaction, and obtaining the intermediate product 2 after purification:
[0027] (c) Dissolving the intermediate product 1 and the condensing agent in an organic solvent, adding the intermediate product 2, reacting under an alkaline catalyst, and obtaining the product after purification:
[0028] (d) As raw material, repeat steps (a)-(c) to obtain long-chain collagen polypeptide; the number of repetitions is x-1;
[0029] Preferably, n is 2, 4, 8, 16, 32, or 64.
[0030] Furthermore, in step (a), the metal catalyst is carbon-supported palladium; the equivalent ratio of the tripeptide protected by the protecting group to the metal catalyst is 1:0.005-0.02; the organic solvent is methanol, and the reaction time is 3-8 hours;
[0031] Preferably, in step (a), the equivalent ratio of the tripeptide protected by the protecting group to the metal catalyst is 1:0.01; and the reaction time is 6 hours.
[0032] The present invention also provides a method for preparing a deprotected long-chain collagen-like polypeptide, the method comprising the following steps:
[0033] (i) preparing a long-chain collagen polypeptide according to the above method:
[0034]
[0035] (ii) reacting the long-chain collagen polypeptide with an inorganic carbonate in an organic solvent to remove R1; then reacting with a metal catalyst under the action of hydrogen to remove R2; finally reacting with a deprotecting agent to remove R3, and obtaining the deprotected long-chain collagen polypeptide after purification:
[0036] The present invention also provides a method for preparing an amino-terminally protected long-chain collagen-like polypeptide, the method comprising the following steps:
[0037] 1. preparing a deprotected long-chain collagen polypeptide according to the above method;
[0038] 2. The deprotected long-chain collagen polypeptide is reacted with a protective agent in an organic solvent to obtain an amino-terminally protected long-chain collagen polypeptide: R5 is an amino protecting group, preferably an acetyl group.
[0039] In summary, the present invention provides an iterative exponential synthesis method for preparing long-chain collagen-like polypeptides. The method uses a liquid-phase iterative exponential synthesis method to connect proline, hydroxyproline and glycine according to a specific sequence to accurately prepare tripeptides; then, the liquid-phase iterative exponential synthesis strategy is used to connect the tripeptides to form collagen-like polypeptide precursors with different lengths; finally, the protective groups at the ends and side chains of the collagen-like polypeptide precursors are removed to prepare long-chain collagen-like polypeptides. The long-chain collagen-like polypeptides prepared by the method have a precise chemical structure and uniform chain length. The present invention adopts a liquid-phase iterative exponential synthesis strategy, which makes the molecular weight of the polypeptide increase exponentially during the synthesis process, reduces the reaction steps, improves the synthesis efficiency of long-chain collagen-like polypeptides, has the advantages of large-scale synthesis and low cost, and can accurately prepare a variety of functionalized long-chain collagen-like polypeptides.
[0040] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.
[0041] The above contents of the present invention are further described in detail below through specific implementation methods in the form of examples. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 Reaction flow chart for preparing the synthetic unit.
[0043] Figure 2 Schematic diagram of the preparation of long-chain collagen peptides.
[0044] Figure 3 HPLC and LC-MS spectra of the synthetic unit dipeptide (Boc-POG-OBn).
[0045] Figure 4 HPLC and LC-MS spectra for the preparation of the synthetic unit tripeptide (Boc-(POG)2-OBn).
[0046] Figure 5 The HPLC spectrum and LC-MS spectrum of long-chain collagen polypeptide (Boc-(POG)8-OBn) are shown. DETAILED DESCRIPTION
[0047] The raw materials and equipment used in the present invention are all known products, which are obtained by purchasing commercially available products.
[0048] Unless otherwise specified, the reactions were carried out at room temperature (25±5°C).
[0049] Example 1: Preparation of long-chain collagen-like polypeptides by iterative exponential synthesis
[0050] 1. Preparation of Boc-O OAc G-OBn (abbreviated as O OAc G)
[0051] 10g Boc-L-hydroxyproline (Boc-O OH -OH) was mixed with benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU) and N,N-diisopropylethylamine (DIEA) and dissolved in 100 mL of N,N-dimethylformamide (DMF), and glycine benzyl hydrochloride (HCl·NH2-G-OBn) was added, wherein the equivalent ratio was: Boc-O OH -OH:HBTU:DIEA:HCl·NH2-G-OBn=1:0.95:3:1.05, react for 4 hours. After the reaction is complete, slowly drop acetic anhydride liquid and imidazole, and add 4-dimethylaminopyridine solid (DMAP), wherein the equivalent ratio is: imidazole:DMAP: acetic anhydride=2:2:1, and continue to react for 2 hours. The reaction flow chart is as follows Figure 1 shown.
[0052] After the reaction was complete, an equal volume of water was added to the reaction solution, and the product was first extracted with ethyl acetate (EA), and then back-extracted with pure water and saturated brine for 3 times to remove the remaining DMF in EA, and then water was absorbed with anhydrous sodium sulfate and concentrated under reduced pressure to an oily liquid to obtain O OAc G, the yield was 96%. The purity and molecular weight were confirmed by HPLC and LC-MS, and the HPLC purity was 98%.
[0053] 2. Preparation of HCl·NH2-O OAc G
[0054] The O obtained in step 1 OAc G was dissolved in dichloromethane (DCM), and 1,4-epoxyhexacyclic hydrochloride was added, wherein the equivalent ratio was 0 OAc G: 1,4-epoxyhexacyclopentane hydrochloride = 1:10, O OAc The mass volume ratio of G to DCM was 1:1 g / mL. Stir at room temperature for 1 hour. After the reaction was completed, the solvent was removed, and the above product was precipitated with glacial ether. The filter cake was dried to obtain HCl·NH2-O OAc G, the yield is 99%, HPLC purity is 98%. The reaction flow chart is as follows Figure 1 shown.
[0055] 3. Preparation of Boc-PO OAc G-OBn (abbreviated as PO OAc G)
[0056] Mix Boc-L-proline (Boc-P-OH), ethyl 2-oxime cyanoacetate (Oxyma), and N,N'-diisopropylcarbodiimide (EDCI) and dissolve them in DCM. Add HCl·NH2-0 OAc G, react at room temperature for 4 hours under alkaline conditions (pH = 8) provided by triethylamine. The equivalent ratio is Boc-P-OH: Oxyma: EDCI: HCl·NH2-O OAc G: triethylamine = 1:2:2:1.1:1.1, the mass volume ratio of Boc-P-OH to DCM is 1:10 g / mL. The reaction flow chart is as follows Figure 1 shown.
[0057] After the reaction is complete, an equal volume of water is added to the reaction solution, and the product is first extracted with ethyl acetate (EA), and then back-extracted with pure water and saturated brine for 3 times to remove the remaining DMF in EA, and then water is absorbed with anhydrous sodium sulfate and concentrated under reduced pressure to an oily liquid to obtain PO OAc G, the yield is 97%. The purity and molecular weight were confirmed by HPLC and LC-MS, and the HPLC purity was 95%. The HPLC spectrum and LC-MS spectrum are shown in Figure 3 shown.
[0058] 4. Preparation of PO OAc G-OH
[0059] The PO obtained in step 3 OAc G was dissolved in methanol (MeOH) and a catalyst carbon-supported palladium (Pd / C) was added, wherein the equivalent ratio was PO OAc G: Pd / C = 1:0.01, PO OAcThe mass volume ratio of G to MeOH was 1:10 g / mL. Hydrogen was passed through and the reaction was carried out for 5 hours. After the reaction was completed, the mixture was filtered under reduced pressure and the solvent was dried to obtain PO. OAC G-OH, the yield is 100%, HPLC purity is 98%. The reaction flow chart is as follows Figure 2 shown.
[0060] 5. Preparation of HCl·HN-PO OAc G
[0061] The PO obtained in step 3 OAc G was dissolved in DCM and 1,4-epoxyhexacyclic hydrochloride was added, where the equivalent ratio was PO OAc G: 1,4-epoxyhexacyclic hydrochloride = 1:10, PO OAc The mass volume ratio of G to DCM was 1:1 g / mL. Stir at room temperature for 1 hour. After the reaction was completed, the solvent was removed, and the above product was precipitated with glacial ether. The filter cake was dried to obtain HCl·HN-PO OAc G, the yield is 99%, HPLC purity is 95%. The reaction flow chart is as follows Figure 2 shown.
[0062] 6. Preparation (PO OAc G)2
[0063] The PO obtained in step 4 OAc G-OH, Oxyma and EDCI were dissolved in DMF, and HCl·HN-PO obtained in step 5 was added. OAc G, reacted under alkaline conditions (pH = 8) provided by triethylamine for 4 hours. The equivalent ratio is PO OAc G-OH: Oxyma: EDCI: HCl·NH2-PO OAc G: triethylamine = 1:2:2:1.1:1.1, PO OAc The mass volume ratio of G-OH to DMF is 1:10 g / mL. The reaction flow chart is as follows Figure 2 shown.
[0064] After the reaction was completed, the reaction solution was concentrated under reduced pressure, and extracted three times with pure water and DCM in a ratio of 1:1. The DCM layer was collected, extracted twice with a saturated Na2CO3 solution, and then washed once with a saturated sodium chloride aqueous solution. The organic phase was collected, dried with anhydrous Na2SO4, and concentrated under reduced pressure to obtain a light yellow oily liquid. The crude product was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 60 / 40) to obtain (PO OAc G) 2, the yield is 82%. The purity and molecular weight of the product were confirmed by HPLC and LC-MS, and the HPLC purity was 95%. The HPLC spectrum and LC-MS spectrum are as follows Figure 4 shown.
[0065] 7. Preparation (PO OAc G)2-OH
[0066] The obtained (PO OAc G)2 was dissolved in MeOH and Pd / C was added, where the equivalent ratio was (PO OAc G)2: Pd / C = 1:0.01, (PO OAc The mass volume ratio of G)2 to MeOH was 1:10 g / mL. Hydrogen was passed through and the reaction was continued for 5 hours. After the reaction was completed, the mixture was filtered under reduced pressure and dried to obtain (PO OAc G) 2-OH, the yield is 100%, HPLC purity is 98%. The reaction flow chart is as follows Figure 2 shown.
[0067] 8. Preparation of HCl·HN-(PO OAc G)2
[0068] The obtained (PO OAc G)2 was dissolved in DCM, and 1,4-epoxyhexacyclic hydrochloride was added, wherein the equivalent ratio was (PO OAc G)2: 1,4-epoxyhexacyclic hydrochloride = 1:10, (PO OAc The mass volume ratio of G)2 to DCM was 1:1 g / mL. The reaction was carried out at room temperature for 1 hour. After the reaction was completed, the product was precipitated by vacuum rotary evaporation using icy ether, and the filter cake was dried to obtain HCl·HN-(PO OAc G) 2, the yield is 96%, HPLC purity is 95%. The reaction flow chart is as follows Figure 2 shown.
[0069] 9. Preparation (PO OAc G)4
[0070] The obtained (PO OAc G) 2-OH was mixed with Oxyma and EDCI and dissolved in DMF. The HCl·HN-(PO OAc G)2 was added to the reaction solution, and the reaction was continued for 4 hours under the alkaline condition (pH = 8) provided by triethylamine. OAc G)2-OH:Oxyma:EDCI:HCl·HN-(PO OAc G)2: triethylamine = 1:2:2:1.1:1.1, (PO OAc G) The mass volume ratio of 2-OH to DMF is 1:10 g / m. The reaction flow chart is as follows Figure 2 shown.
[0071] After the reaction was completed, the reaction solution was concentrated under reduced pressure, and extracted three times with pure water and DCM in a ratio of 1:1. The DCM layer was collected, extracted twice with a saturated Na2CO3 solution, and then washed once with a saturated sodium chloride aqueous solution. The organic phase was collected, dried with anhydrous Na2SO4, and concentrated under reduced pressure to obtain a light yellow oily liquid. The crude product was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 60:40) to obtain (PO OAc G) 4, the yield was 82%, the purity and molecular weight of the product were confirmed by HPLC and LC-MS, and the HPLC purity was 98%.
[0072] 10. Repeat the above steps to obtain HCl·HN-(PO OAc G) n , Boc-(PO OAc G) n -OH, prepare the corresponding (PO OAc G) 2n (n=4,8,16,32, etc.). OAc G) HPLC spectrum and LC-MS spectrum of 8 are as follows Figure 5 shown.
[0073] 11. Removal (PO OR G) n The protective groups of the precursor terminal and side chains are (PO OR G) 4 as an example:
[0074] (a) First, (PO OR G) 4 and potassium carbonate were mixed and dissolved in methanol solution, stirred for 6 hours, and the acetyl group of the side chain was removed to obtain intermediate product 1. Among them, (PO OR G) 4. The equivalent ratio of potassium carbonate is 1:3, (PO OR G) The mass volume ratio of 4 to methanol is 1:10 g / mL.
[0075] (b) Then, under the action of hydrogen, the catalyst carbon-supported palladium (Pd / C) was reacted for 5 hours to remove the benzyl group on the intermediate product 1 to obtain the intermediate product 2. The equivalent ratio of the intermediate product 1 to Pd / C is 1:0.01.
[0076] (c) Finally, 1,4-epoxyhexacyclopentane hydrochloride was used to react for 1 hour to remove the tert-butyloxycarbonyl group on the intermediate product 2. The equivalent ratio of the intermediate product 2 to 1,4-epoxyhexacyclopentane hydrochloride was 1:10. After the reaction was completed, the solvent was concentrated, and the above product was precipitated with glacial ether, and the filter cake was dried to obtain the corresponding product.
[0077] The total yield of steps (a)-(c) is 95%, and the product purity is 90%.
[0078] 12. Protection of the amino terminus of the CLP precursor. Dissolve the product obtained in step 11 in DMF, slowly drop acetic anhydride liquid into the solution, and react at room temperature for 1 hour. The equivalent ratio of the product obtained in step 11 to acetic anhydride is 1:4. After the reaction is completed, concentrate the solvent to obtain CLP with the amino terminus of the precursor protected by an acetyl group. The yield of this step is 95%, and the product purity is 95%.
[0079] The beneficial effects of the present invention are demonstrated by experimental examples below.
[0080] Experimental Example 1: Preparation of O OAc Screening experiment of G.
[0081] Method 1:
[0082] 10g Boc-L-hydroxyproline (Boc-O OH -OH) and benzyl bromide were mixed and dissolved in N,N-dimethylformamide (DMF), potassium carbonate powder was added, and after reacting for 2 hours, 4-dimethylaminopyridine (DMAP) solid was added to the reaction solution, followed by acetic anhydride as a protective agent, and the reaction was continued for 4 hours. OH The equivalent ratio of -OH, benzyl bromide, potassium carbonate, DMAP, and acetic anhydride is 1:2:2:1.1:1.1, and Boc-O OH The mass volume ratio of -OH to DMF was 1:10 g / mL. After the reaction was completed, Boc-O OR -OBn. OR -OBn was dissolved in methanol (MeOH), and the catalyst carbon-supported palladium (Pd / C) was added and hydrogen was passed. OR -OB and Pd / C, Boc-O OR The mass volume ratio of -OB to MeOH was 1:10 g / mL. After 5 hours of reaction, the mixture was filtered under reduced pressure and dried by spin drying to obtain Boc-O OR -OH. The yield of these two steps is 97%.
[0083] Boc-O OR -OH, benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU), and N,N-diisopropylethylamine (DIEA) were mixed and dissolved in DMF, and glycine benzyl ester hydrochloride (HCl·NH2-G-OBn) was added and reacted for 3 hours; after the reaction was complete, extraction and concentration under reduced pressure were performed to obtain Boc-O OR The yield of this step is 96%, Boc-O OR The purity of G-OBn was 95%.
[0084] Method 2:
[0085] Same as step 1 in Example 1.
[0086] The route in method 1 is too complicated and time-consuming, so method 2 is selected for dipeptide Boc-O OR Preparation of G-OBn.
[0087] Experimental Example 2: Preparation of HCl·NH2-O OR Screening experiment of G.
[0088] Method 1:
[0089] The O obtained in step 1 of Example 1 OR G was dissolved in dichloromethane (DCM), and 1,4-epoxyhexacyclopentane hydrochloride was added and stirred at room temperature for 1 hour. OR The equivalent ratio of G to 1,4-epoxyhexacyclic hydrochloride is the same as that in step 2 of Example 1. OR The mass volume ratio of G and DCM is the same as that in step 2 of Example 1. After the reaction is completed, the solvent is removed to obtain HCl·NH2-O OR G. The yield of this step was 100% and the HPLC purity was 98%.
[0090] Method 2:
[0091] Same as step 2 of Example 1.
[0092] The purity of the product obtained in method 1 is not ideal, so method 2 is selected to carry out HCl·NH2-O OR Preparation of G.
[0093] Experimental Example 3: Preparation of PO OR Screening experiment of G.
[0094] Method 1:
[0095] Boc-L-proline (Boc-P-OH) was mixed with HOBT and DIEA and dissolved in DMF. After activation for 0.5 hours, HCl NH-O OR G-OBn, react at room temperature for 4 hours; after the reaction, the reaction solution was concentrated under reduced pressure, extracted 3 times with pure water and DCM, the ratio of pure water to DCM was 1:1, the DCM layer was collected, extracted 2 times with saturated Na2CO3 solution, and then washed once with saturated sodium chloride aqueous solution, the organic phase was collected, dried with anhydrous Na2SO4, and concentrated under reduced pressure to obtain a light yellow oily liquid. The crude product was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 55:45) to obtain Boc-PO OR The yield of the product in this step was 82%, and the purity according to HPLC was 98%.
[0096] Method 2:
[0097] Same as step 3 of Example 1.
[0098] The HOBT activator used in method 1 produces more by-products, and the purification operation is complicated and difficult. Column chromatography is required for purification, and the product yield is low. Therefore, method 2 is selected for PO OR Preparation of G.
[0099] In summary, the present invention provides an iterative exponential synthesis method for preparing long-chain collagen-like polypeptides. The long-chain collagen-like polypeptides prepared by the method have precise chemical structures and uniform chain lengths. The present invention adopts a liquid phase iterative exponential synthesis strategy, which allows the molecular weight of the polypeptide to increase exponentially during the synthesis process, reduces the reaction steps, improves the synthesis efficiency of long-chain collagen-like polypeptides, has the advantages of large-scale synthesis and low cost, and can accurately prepare a variety of functionalized long-chain collagen-like polypeptides.
Claims
1. A method for preparing long-chain collagen polypeptides, characterized in that: The method comprises the following steps: (I) preparing a tripeptide protected by a protecting group; (II) using a tripeptide protected by a protecting group as a raw material and utilizing an iterative exponential synthesis method to prepare a long-chain collagen-like polypeptide; The structure of the tripeptide protected by the protecting group is The structure of the long-chain collagen-like polypeptide is R1 is a hydroxyl protecting group, R2 is a carboxyl protecting group, R3 is an amino protecting group, n is 2 to the power of x, and x is an integer greater than or equal to 1.
2. The method according to claim 1, characterized in that: Step (I) The method for preparing a tripeptide protected by a protecting group comprises the following steps: (1) Dissolving the hydroxyproline protected by a protecting group, a coupling agent and a basic catalyst in an organic solvent, adding the glycine protected by a protecting group to carry out a condensation reaction, and then adding a protecting agent, an imidazole compound and a catalyst to carry out an upper protection reaction, and obtaining a dipeptide product protected by a protecting group after purification: R4 is an amino protecting group; (2) dissolving the dipeptide product protected by the protecting group and the deprotecting agent in an organic solvent to carry out a deprotection reaction, and obtaining the dipeptide product with the deprotected group after purification: (3) dissolving the proline protected by the protecting group and the condensing agent in an organic solvent, adding the dipeptide product with the deprotected group, reacting under an alkaline catalyst, and obtaining the collagen-like tripeptide protected by the protecting group after purification.
3. The method according to claim 2, characterized in that: The hydroxyl protecting group is acetyl, tert-butyloxycarbonyl, tert-butyldiphenylsilyl or methoxymethyl, the carboxyl protecting group is benzyl, acetyl, tert-butyloxycarbonyl, tert-butyldiphenylsilyl or methoxymethyl, and the amino protecting group is tert-butyloxycarbonyl, acetyl, tert-butyldiphenylsilyl or methoxymethyl.
4. The method according to claim 3, characterized in that: In step (1), the hydroxyproline protected by the protecting group is Boc-L-hydroxyproline, the coupling agent is benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate; the alkaline catalyst is N,N-diisopropylethylamine, the glycine protected by the protecting group is glycine benzyl ester hydrochloride, the organic solvent is N,N-dimethylformamide, and the hydroxyproline protected by the protecting group is benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate. The equivalent ratio of urea hexafluorophosphate: N, N-diisopropylethylamine: protective group protected glycine is 1: 0.5-1: 2-5: 1-1.2, and the condensation reaction time is 1-5 hours; the protective agent is acetic anhydride, the imidazole compound is imidazole, the catalyst is 4-dimethylaminopyridine, the equivalent ratio of acetic anhydride: imidazole: 4-dimethylaminopyridine is 1: 1-3: 1-3, and the upper protection reaction time is 1-3 hours; In step (2), the deprotecting agent is 1,4-epoxyhexacyclic ring or its salt, the organic solvent is dichloromethane, the equivalent ratio of the dipeptide product protected by the protecting group to the deprotecting agent is 1:9-11; the mass volume ratio of the dipeptide product protected by the protecting group to the organic solvent is 1:0.5-2; the deprotection reaction time is 0.5-2 hours; In step (3), the proline protected by the protecting group is Boc-L-proline; the condensing agent is one or a mixture of two or more of ethyl 2-oxime cyanoacetate, O-benzotriazole-tetramethyluronium hexafluorophosphate, 2-(7-azobenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate, and N,N'-diisopropylcarbodiimide; the organic solvent is dichloromethane, and the alkaline catalyst is triethylamine; the equivalent ratio of the proline protected by the protecting group, the dipeptide product of the deprotecting group, the condensing agent, and the alkaline catalyst is 1:1-3:2-4:1-2; the mass volume ratio of the proline protected by the protecting group to the organic solvent is 1:9-11; and the reaction time is 2-6 hours.
5. The method according to claim 4, characterized in that: In step (1), the equivalent ratio of the protecting group-protected hydroxyproline: benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate: N,N-diisopropylethylamine: protecting group-protected glycine is 1:0.95:3:1.05, and the condensation reaction time is 4 hours; the equivalent ratio of acetic anhydride: imidazole: 4-dimethylaminopyridine is 1:2:2; and the top protection reaction time is 2 hours; In step (2), the deprotecting agent is 1,4-epoxyhexacyclopentane hydrochloride, the equivalent ratio of the dipeptide product protected by the protecting group to the deprotecting agent is 1:10; the mass volume ratio of the dipeptide product protected by the protecting group to the organic solvent is 1:1; and the deprotection reaction time is 1 hour; In step (3), the condensing agent is ethyl 2-oxime cyanoacetate and N,N'-diisopropylcarbodiimide, the equivalent ratio of the proline protected by the protecting group, the dipeptide product of the deprotected group, ethyl 2-oxime cyanoacetate, N,N'-diisopropylcarbodiimide, and the alkaline catalyst is 1:2:2:1.1:1.1; the mass volume ratio of the proline protected by the protecting group to the organic solvent is 1:10, and the reaction time is 4 hours.
6. The method according to claim 2, characterized in that: The purification method of step (1) is as follows: after the reaction is completed, water is added to the reaction solution, the product is extracted with ethyl acetate, and then back-extracted with water and saturated saline, and then water is absorbed with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the product; The purification method of step (2) is: after the reaction is completed, the solvent is removed and precipitation is performed using glacial ether to obtain; The purification method of step (3) is as follows: after the reaction is completed, water is added to the reaction solution, the product is first extracted with ethyl acetate, then back-extracted with water and saturated brine, then water is absorbed with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the product.
7. The method according to any one of claims 1 to 6, characterized in that: Step (II) comprises the following operations: (a) Using a tripeptide protected by a protecting group as a raw material, a deprotection reaction is carried out with a metal catalyst in an organic solvent, and an intermediate product 1 is obtained after purification: (b) dissolving the tripeptide protected by the protecting group and the deprotecting agent in an organic solvent to carry out a deprotection reaction, and obtaining the intermediate product 2 after purification: (c) Dissolving the intermediate product 1 and the condensing agent in an organic solvent, adding the intermediate product 2, reacting under an alkaline catalyst, and obtaining the product after purification: (d) As raw material, repeat steps (a)-(c) to obtain long-chain collagen polypeptide; the number of repetitions is x-1; Preferably, n is 2, 4, 8, 16, 32, or 64.
8. The method according to claim 7, characterized in that: In step (a), the metal catalyst is carbon-supported palladium; the equivalent ratio of the tripeptide protected by the protecting group to the metal catalyst is 1:0.005-0.02; the organic solvent is methanol, and the reaction time is 3-8 hours; Preferably, in step (a), the equivalent ratio of the tripeptide protected by the protecting group to the metal catalyst is 1:0.01; and the reaction time is 6 hours.
9. A method for preparing a deprotected long-chain collagen polypeptide, characterized in that: The method comprises the following steps: (i) preparing a long-chain collagen polypeptide according to the method described in any one of claims 1 to 9: (ii) reacting the long-chain collagen polypeptide with an inorganic carbonate in an organic solvent to remove R1; then reacting with a metal catalyst under the action of hydrogen to remove R2; finally reacting with a deprotecting agent to remove R3, and obtaining the deprotected long-chain collagen polypeptide after purification:
10. A method for preparing an amino-terminally protected long-chain collagen-like polypeptide, characterized in that: The method comprises the following steps:
1. preparing the deprotected long-chain collagen polypeptide according to the method of claim 9; 2. The deprotected long-chain collagen polypeptide is reacted with a protective agent in an organic solvent to obtain an amino-terminally protected long-chain collagen polypeptide: R5 is an amino protecting group, preferably an acetyl group.
Citation Information
Patent Citations
Dual stimuli-responsive collagen polypeptide polymer and preparation method thereof
CN106397577A
Method for producing collagen-like polypeptide
US20140128573A1
Collagen mimics
US5973112A
Membrane for biopolymer synthesis and biopolymer synthesis method using same
WO2023234718A1
